HPV vaccine prevents childhood respiratory disease

The vaccine that protects against cancer-causing types of human papillomavirus HPV also prevents an uncommon but incurable childhood respiratory disease, the chronic and difficult-to-treat condition, recurrent respiratory papillomatosis.

The condition is thought to occur in children when HPV type 6 or 11 is spread from mother to child around the time of birth. In some children, the virus can cause wart-like, non-cancerous growths called papillomas to develop in the respiratory tract, eventually making it difficult to breathe.

 The condition can be life-threatening, and repeated surgeries are usually required to keep the airway clear. Medical costs related to the disease in children. The Centers for Disease Control and Prevention CDC currently recommends two doses of the vaccine for teens younger than 15 and three doses for those who start the vaccine series at ages 15 through 26.

Recurrent respiratory papillomatosis is an uncommon but difficult-to-treat respiratory disease caused by certain types of human papillomavirus HPV. In children, the chronic disease is thought to occur when HPV is spread from mother to child around the time of birth, later causing recurring growths in the respiratory tract that usually require repeated surgeries to remove.
           haleplushearty.blogspot.com